BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
FDA Accepts Gilead Sciences, Inc.'s Two NDAs For HIV Therapy     4/22/2014   More...
GlaxoSmithKline's ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool     4/2/2014   More...
Merck & Co., Inc. HIV Drug Strategy Seen Shielding Patent     3/21/2014   More...
Bay Area's Sangamo BioSciences, Inc. Surges As Gene Editing Tech Make Cells Repel HIV     3/6/2014   More...
Merck & Co., Inc.'s Investigational Hepatitis C Drugs Work In HIV Co-Infected Patients In Phase 2 Study     3/6/2014   More...
AbbVie AIDS Drug Clears Pre-Cancerous Lesions In Kenyan Study     2/18/2014   More...
European Commission (EC) Approves Gilead Sciences, Inc.'s Vitekta™, To Treat HIV-1 Infection     11/18/2013   More...
FDA Approves GlaxoSmithKline's HIV Drug     8/14/2013   More...
FDA Ordered to Cough Up Docs Regarding Gilead Sciences, Inc. Drug     8/8/2013   More...
Roche Cuts Cost of Drug to Prevent Blindness in HIV Patients     8/6/2013   More...
GlaxoSmithKline, Johnson & Johnson Combination May Control HIV With Monthly Injections     7/3/2013   More...
Gilead Sciences, Inc.'s Viread Reduces HIV Risk for Drug Users in Study     6/13/2013   More...
European Commission (EC) Approves Gilead Sciences, Inc.'s Stribild as Single Tablet Regimen for HIV-1 Treatment     5/28/2013   More...
Gilead Sciences, Inc. Fails FDA Approval for Two HIV Drugs in 4-in-1 Pill     5/6/2013   More...
India Rejects Bayer AG Plea Against Cheap Cancer Drug     3/5/2013   More...
 Featured Stories
Man Who Co-Discovered HIV Reveals Why There Won’t Be A Cure For AIDS     4/24/2014   More...
Transplant Drugs May Help Wipe Out Persistent HIV Infections, University of California, San Francisco (UCSF) Study     4/3/2014   More...
Good Bacteria That Protects Against HIV Identified, University Of Texas Medical Branch At Galveston Study     3/31/2014   More...
Women Can Get HIV From Other Women During Sex, Centers for Disease Control and Prevention (CDC) Reports     3/17/2014   More...
Early HIV Treatment May Have Cured Second U.S. Baby, Johns Hopkins University Reveals     3/6/2014   More...
Potent HIV Antibody Research Has Opened Up Possibilities For HIV Prevention, Treatment, National Institute of Allergy And Infectious Diseases (NIAID) And Columbia University Study     3/4/2014   More...
Injected Virus Protects Mice From HIV, California Institute of Technology Study     2/11/2014   More...
New HIV/AIDS Discovery Shows How Wrong Assumptions Can Be     2/3/2014   More...
HIV Returns In 2 Men Who Showed Signs Of "Cure"     12/9/2013   More...
Vitamin-Supplement Combo Slows HIV Progress, Florida International University Reveals     11/27/2013   More...
Global HIV Vaccine Shows Promise in Monkeys, Beth Israel Deaconess Medical Center Study     10/25/2013   More...
Breast Milk Protein May Be Key to Protecting Babies From HIV, Duke University Medical Center Study     10/22/2013   More...
Soybean Compound May Inhibit HIV Infection, George Mason University Study     7/30/2013   More...
How HIV Kills Immune Cells, National Institute of Allergy And Infectious Diseases (NIAID) Study     6/6/2013   More...
Discovery May Help Prevent HIV: Insights Into Eliminating Reservoirs of HIV-1, Albert Einstein College of Medicine Study     4/18/2013   More...
 More News
Bristol-Myers Squibb Company (BMY) Submits New Drug Application To FDA For A Fixed-Dose Combination Tablet Of Atazanavir Sulfate With Cobicistat For People Living With HIV-1     4/14/2014   More...
Immune Response BioPharma Announces FDA BLA Fee Waiver Granted Clears Path For REMUNE Approval     4/2/2014   More...
Janssen Research & Development Submits New Drug Application To FDA For A Fixed-Dose Combination Tablet Of HIV-1 Medicine Darunavir With Cobicistat As Part Of Combination HIV Therapy     4/2/2014   More...
Argos Therapeutics, Inc. (ARGS) Presents New Data From Clinical Research For AGS-004 Patient-Specific Immunotherapy In Treatment Of HIV     3/5/2014   More...
XOMA Corporation (XOMA)’s Investigational HIV Therapy, Doravirine (MK-1439), Demonstrates Antiviral Activity In Phase 2B Study Of Treatment-Naïve Adults     3/5/2014   More...
Merck & Co., Inc. (MRK)'s Investigational HIV Therapy, Doravirine (MK-1439), Demonstrates Antiviral Activity In Phase 2B Study Of Treatment-Naïve Adults     3/5/2014   More...
Merck & Co., Inc. (MRK) Release: New 96-Week ACTG Study Results Presented At CROI 2014; First Large Study Comparing ISENTRESS® (Raltegravir) Regimen To Two Protease Inhibitor Regimens In Previously Untreated Adults With HIV-1     3/5/2014   More...
Massachusetts Biotechnology Council, Inc. Release: Startups Solving Problems In HIV, PTSD, VHL And Diabetes Chosen For MassCONNECT Mentoring     2/24/2014   More...
CytoDyn Submits Protocol To FDA For Phase 2b Clinical Study Of PRO 140 For Treatment Substitution In Patients With HIV     2/18/2014   More...
Immune Response BioPharma Announces REMUNE Granted Orphan Designation For Pediatric HIV/AIDS     2/18/2014   More...
Immune Response BioPharma To Develop Annual HIV Vaccine RemuneVax Based On Current HIV Strain     12/23/2013   More...
FDA Approves Gilead Sciences, Inc. (GILD)'s Once-Daily Single Tablet HIV-1 Regimen     12/16/2013   More...
InnaVirVax Initiates Phase 2 Clinical Trial Evaluating VAC-3S, A Therapeutic Vaccine Used In Combination With Standard Antiretroviral Therapy In Treatment Of HIV-Infection     12/2/2013   More...
AbbVie (ABBV) Partners With HIV Community To Launch International Awareness Campaign Focused On Women Living With HIV     11/26/2013   More...
ViiV Healthcare Release: Tivicay® (dolutegravir) Receives Positive CHMP Opinion In Europe For The Treatment Of HIV     11/22/2013   More...

 

 

//-->